Antibody cocktail therapy begins at Sir Ganga Ram Hospital

June 1, 2021

India

healthysoch

New Delhi, June 01, 2021 :

Sir Ganga Ram Hospital has commenced administration of Monoclonal Antibody Cocktail (MAC) from 01 June 2021, a combination of Casirivimab & Imdevimab to consenting patients with mild & moderate Covid-19 symptoms at high risk of developing serious illness. As per Drug Controller General of India (DCGI), selection of patients will entail that they:

(A) have Covid-19 Positive test report.
(B) have mild to moderate Covid disease.
(C) are in the age group of 12 & above and weighing at least 40Kg.
(D) are at high risk of Covid-19.

The MRP of one MAC dose for a patient will be Rs. 59,750/- only.
According to Dr. D.S. Rana, Chairman (BOM), Sir Ganga Ram Hospital said, “As per the claims of the company Roche/ Cipla we hope MAC will be a major factor in fight against Covid-19 to prevent disease from progressing to further severity”.

healthysoch

Stay informed with the latest news from HealthySoch. Sign up today for exclusive insights and updates!

We promise we never spam!

Leave a Reply

Your email address will not be published.

Columnists

HealthySoch

Don't Miss

AstraZeneca expands its portfolio by bringing rare disease therapy for patients in India

AstraZeneca completed the acquisition of Alexion in the year 2021

One should learn to fight illness like Shri Atal Bihari Vajpayee

Former Prime Minister Shri Atal Bihari Vajpayee passes away New